Pathology Analysis & Statistics, May 2012

HIV Statistics and Forecast

$ 11 400
Industry report
February 2012
by Datamonitor

About This Report In 2009, HIV antiretroviral sales across the seven major industry s totalled USD 11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations ...

Industries : Pathology
Countries : United States, Spain, Italy, France, Germany, Europe, United Kingdom

Health Statistics : Dyslipidemia - Undertreated and underdiagnosed pandemic

$ 5 700
Industry report
February 2012
by Datamonitor

The large numbers of adults with dyslipidemia in the seven major industry s can be directly attributed to lifestyle choices, such as high caloric intake and limited physical activity. There is a clea ...

Industries : Pathology
Countries : Germany, United States, United Kingdom, Spain, Italy, France, Japan, World, Europe

Global Endometriosis Industry

$ 4 600
Industry report
March 2012
by Global Industry Analyst

This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates ...

Industries : Pathology
Countries : World

Global Breath Analyzers Industry

$ 4 500
Industry report
March 2012
by Global Industry Analyst

This report analyzes the worldwide markets for Breath Analyzers in Thousands of US Dollars by the following End-Use Segments: Regulatory Authorities, Employee Screening, and Healthcare. The report provides ...

Industries : Pathology
Countries : World

Triple Analysis: Lymphoma, Prostate Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Lymphoma, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Melanoma, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Lymphoma, Melanoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is ...

Industries : Pathology

Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Leukemia and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Breast Cancer, Apoptosis and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

Industries : Pathology

Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

Industries : Pathology

Triple Analysis: Colorectal Cancer, Prostate Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology

Triple Analysis: Leukemia, Pancreatic Cancer and Protein Kinase Inhibitors

$ 5 003
Company report
May 2012
by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

Industries : Pathology